MAPT and supranuclear palsy, progressive, 1: Quantitative analyses show that tau-PET differentiates PSP from PD with sensitivities of 80–90%, specificities of 85–92%, and AUC values between 0.88 and 0.94, particularly when assessing binding in the globus pallidus, putamen, subthalamic nucleus, midbrain, and dentate nucleus [136].